© Copyright Esol link
IVD Quality Control Market in terms of revenue was estimated to be worth $1.3 billion in 2022 and is poised to reach $1.6 Billion by 2027, growing at a CAGR of 5.4% from 2022 to 2027 according to a new report by MarketsandMarkets™. The growth of the IVD quality control market is driven by the rising number of accredited clinical laboratories, rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases and increasing adoption of third-party quality controls. The rising focus on multi-analyte controls and Increasing investments from government bodies and private players in healthcare sectors in emerging economies is also expected to offer significant growth opportunities for the market in the coming years. Lack of regulations for clinical laboratory accreditation in several emerging countries could be the challenges faced by the market in upcoming years.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582
The product & service segment holds the highest share of the total IVD quality control market during the forecast period.
The quality control products segment accounted for the largest share of the IVD quality control market in the base year 2021. The increasing number of accredited laboratories and mandates for the use of quality controls from regulatory bodies are driving the growth of the IVD quality control products market. The growth in the number of IVD tests performed, the increased number of accredited laboratories, and the implementation of mandates from regulatory bodies for ensuring the accuracy of diagnostic test results using QC materials are also some of the major factors influencing this market growth.
Immunochemistry accounted for the highest share of the technology segment of the global IVD quality control market
The immunochemistry segment accounted for the largest share of the IVD quality control market in 2021. The large share of the immunochemistry segment can be attributed to the growing use of immunoassay controls in diagnostics. However, the molecular diagnostics segment is estimated to grow at the highest CAGR of 7.9% during the forecast period, majorly due to the rising prevalence of infectious diseases such as tuberculosis, influenza, pneumonia, and COVID-19.
Third-party controls accounted for the largest share for the IVD quality control market
Based on manufacturer, the IVD quality control market is segmented into third-party controls and OEM controls. The third-party controls segment accounted for the largest share of the global IVD quality control market in 2021. The large share of this segment is mainly attributed to the increasing use of third-party quality controls due to their benefits, such as longer shelf-life and flexibility across different reagent lots, which helps reduce costs. Other benefits include unbiased independent assessment, consistent analyte-level stability, and clinically relevant levels.
Hospitals accounted for the highest share of the global IVD quality control market
The hospitals segment accounted for the largest share of the IVD quality control market in 2021, owing to the large volume of diagnostic tests carried out in hospitals. Clinical laboratories are estimated to be the fastest-growing end-user segment in this market. Amid the COVID-19 pandemic, manufacturers developed a diverse range of controls for clinical laboratories, hospitals, and research centers, as ensuring the accuracy of tests is vital to curb the spread of the outbreak.
Based on Region, North America to dominate the global IVD quality control market
In 2021, North America dominated the global IVD quality control market. Approvals of quality control products from the FDA and the College of American Pathologists (CAP) and the presence of leading companies in the US are driving the IVD quality control market in North America. In 2021, US dominated the North America IVD quality control market. In the coming years, the increasing number of IVD tests; the growing need to ensure the accuracy, reliability, and reproducibility of test results; and the use of third-party quality controls among clinical laboratories in this region will play a key role in the market growth.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198032582
IVD Quality Control Market Dynamics:
Drivers:
Restraints:
Opportunities:
Challenges:
Key Market Players:
Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=198032582
Cell Therapy Technologies Market in terms of revenue was estimated to be worth $4.2 Billion in 2023 and is poised to reach $7.8 Billion by 2028, growing at a CAGR of 13.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. Major factors driving the market growth at significant CAGR are increasing the prevalence of chronic diseases, increasing the funding for research, and the launch of novel products in the market by key market players.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978
The cell processing segment accounted for the largest share of the process segment in the cell therapy technologies market in 2022.
Based on process, the global cell therapy technologies market is segmented into cell processing, cell preservation, distribution & handling, process monitoring & quality control. In 2022, the cell processing segment held dominant share in cell therapy technologies market. The factors attributable to the dominance are adoption of technologically advance products and instruments in the market.
The biopharmaceutical & biotechnology companies sub segment accounted for the largest share of the end user segment in the cell therapy technologies market in 2022.
Based on end users, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies, CROS & CMOs, research institutes & cell banks. In 2022, the biopharmaceutical & biotechnology companies segment accounted for the largest share of the cell therapy technologies market. The segment held the dominant share in the market owing to various factors such as increased funding, rising academia and biopharma collaboration for research and development in cell-therapy products.
North America dominated the cell therapy technologies market.
Based on region, the cell therapy technologies market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America dominated the market, followed by Europe. The increasing funding for research for chronic diseases and the presence of top players operating in the region are key factors supporting the growth of the North America cell therapy technologies market. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Increased adoption of cell-based therapy in emerging countries coupled with emphasis on geographical expansions by key market players in emerging countries these are some of the factors anticipated to contribute to the cell therapy technologies market growth in the Asia Pacific.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=213334978
Cell Therapy Technologies Market Dynamics:
Drivers:
Restraints:
Opportunities:
Challenges:
Key Market Players:
The cell therapy technologies market is consolidated, with a small number of players competing for market shares. Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Lonza Group (Switzerland)Danaher Corporation (US), Sartorius AG (Germany) are some of the leading players in this market. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
Recent Developments:
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=213334978
Empty Capsules Market in terms of revenue was estimated to be worth $3.2 billion in 2023 and is poised to reach $4.9 billion by 2028, growing at a CAGR of 9.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as rising R&D activities in empty capsules and increasing use of nutraceuticals are driving the growth of this market. However, dietary restrictions and cultural practices are the major factors restraining the growth of this market.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190
The gelatin capsules segment accounted for the largest share of the type segment in the empty capsules market in 2022.
Based on type, the empty capsules market is broadly segmented into gelatin capsules, and non-gelatin capsules. In 2022, gelatin capsules accounted for the largest share of the empty capsules market for type. This segment's large share can be attributed to factors such as the availability of gelatin for capsule manufacturing and low cost of gelatin.
The immediate-release capsules segment accounted for the largest share of the functionality segment in the empty capsules market in 2022.
Based on functionality, the empty capsules market is categorized into three segments—immediate-release capsules, sustained-release, and delayed release capsules. In 2022, immediate-release capsules segment accounted for the largest share of empty capsules market. Factors such as the wide utilization of immediate-release capsules in pharmaceutical and cosmetic industry are projecting the segmental growth.
Asia Pacific is likely to grow at double digit growth rate during the forecast period.
The Asia Pacific region is estimated to grow at the highest CAGR in the empty capsules market during the forecast period, this is mainly due to the growth in Asian pharmaceutical markets and their manufacturing capacities. Moreover, fast growing R&D infrastructure along with large number of scientific talents in the countries of this region is likely to boost the market. Also, growing generic drug manufacturing in the region is attracting several foreign investors in the market.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=218018190
Empty Capsules Market Dynamics:
Drivers:
Restraints:
Opportunities:
Challenges:
Key Market Players:
Some of the prominent players in the empty capsules market are Capsugel (US), ACG Worldwide (India), Qualicaps (US), CapsCanada Corporation (Canada), Suheung Co. Ltd., Natural Capsules (India), (Korea), and among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=218018190
Cold Plasma market in terms of revenue was estimated to be worth $1.6 billion in 2021 and is poised to reach $3.3 billion by 2026, growing at a CAGR of 15.0% from 2021 to 2026 according to a latest report published by MarketsandMarkets™. Factors such as the increasing prevalence of food-borne diseases, increasing use of cold plasma in wound healing and cancer treatment, innovation in textile production, and benefits of cold plasma for different industries are expected to drive the growth of the cold plasma industry.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=187065928
Based on industry, the polymer & plastic, textile, electronics & semiconductors, food & agriculture, and medical industries are the leading adopters of cold plasma technology. Of these, the polymer & plastic industry segment accounted for the largest share of the market in 2020. Surface Treatment of the cold plasma technology for the polymer & plastic industry is expected to result in driving the growth of the segment during the forecast period.
Atmospheric cold plasma and low-pressure cold plasma are the two types of regimes available in the commercial market. The atmospheric cold plasma segment is expected to exhibit the fastest CAGR of the cold plasma market during the forecast period. Its advantages over low-pressure cold plasma, low cost, and environment-friendliness have driven the growth of this market segment.
Geographically, the cold plasma market in Europe accounted for the largest share in 2020 due to the presence of a large number of cold plasma companies and growing R&D activity. The Asia Pacific market is expected to register the highest growth during the forecast period, mainly due to the growing demand for cold plasma technology in China, India, Japan, and South Korea, among other APAC countries. Considering this factor, a majority of global companies are focusing on developing and expanding their R&D capabilities and distribution networks in this region.
Key Market Players:
The prominent players in the cold plasma market include Apyx Medical Corporation (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i (UK), Relyon Plasma GmbH, (Germany), Henniker Plasma (UK), Enercon Industries (US), AcXys Plasma Technologies (France), Plasmatreat (Germany), Tantec A/S (Denmark), Europlasma (Belgium), Thierry Corporation (Germany), Surfx Technologies (US), SOFTAL Corona & Plasma (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas GmbH (Germany), terraplasma GmbH (Germany), Molecular Plasma Group (Germany), and CINOGY GmbH (Germany), US Medical Innovation (US).
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=187065928
Hypothetic Challenges of Cold Plasma Market in Near Future:
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=187065928
Life Science Analytics Market in terms of revenue was estimated to be worth $27.1 billion in 2022 and is poised to reach $47.5 billion by 2027, growing at a CAGR of 11.8% from 2022 to 2027 according to a new report by MarketsandMarkets™. The life science analytics market is mainly driven by factors such as rising technological advancements in analytical solutions and increasing adoption of analytics for sales and marketing applications. However, high implementation costs and data privacy concerns are expected to restrain the growth of this market to a certain extent.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653
Browse in-depth TOC on "Life Science Analytics Market"
211 - Tables
45 - Figures
251 - Pages
Life Science Analytics Market Scope:
Report Coverage
Details
Market Revenue in 2022
$27.1 billion
Estimated Value by 2027
$47.5 billion
Growth Rate
Poised to grow at a CAGR of 11.8%
Market Size Available for
2020–2027
Forecast Period
2022–2027
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Type, Component, Delivery Model, Application, End User, and Region
Geographies Covered
North America (US and Canada), Asia (Japan, China, India, and RoA), Europe (Germany, UK, France,Italy, and RoE), and the Rest of the World
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Big data analytics for R&D productivity
Key Market Drivers
Rising pressure to curb healthcare spending
"Descriptive analytics type segment is expected to account for the largest share of the life science analytics market in 2022"
Based on type, the life science analytics market is bifurcated into descriptive analytics, predictive analytics, and prescriptive analytics. In 2022, the descriptive analytics segment was expected to hold the largest share of this market. The large share of this segment is attributed to the major usage of descriptive analytics by stakeholders to gain a clearer understanding of past trends and events arising in real-time.
"Services segment to grow at the highest CAGR in the life science analytics market during the forecast period, by component"
Based on component, the life science analytics market is segmented into services and software. In 2022, the services segment was expected to account for the largest market share of the life science analytics market. This segment is also expected to grow at the highest CAGR during the forecast period, primarily due to the frequent need for services such as software upgrades and maintenance.
"Research & development segment is expected to account for the largest share of the life science analytics market in 2022"
Based on application, the life science analytics market is divided into research & development, sales & marketing, regulatory compliance, supply chain optimization, and pharmacovigilance. In 2022, research & development is expected to account for the largest share of the life science analytics market. However, the sales & marketing segment is estimated to register the highest growth during the forecast period. Factors such as e increasing implementation of analytics by life science companies to support sales and marketing campaigns and increasing importance of post-marketing surveillance are driving the growth of this segment.
"North America is expected to hold the largest share of the life science analytics market in 2022"
Based on region, the life science analytics market is divided into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Factors such as growing adoption of IT in the life science industry, rising pressure to reduce healthcare costs and presence of leading players are driving the growth in North American market.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174990653
Life Science Analytics Market Dynamics:
Drivers:
Restraints:
Opportunities:
Challenges:
Key Market Players:
Prominent players in this market include Oracle (US), IBM (US), SAS Institute Inc. (US), Accenture (Ireland), IQVIA Inc, (US), Cognizant (US), Wipro (India), Allscripts Healthcare, LLC (US), Optum, Inc. (US), Microsoft (US), MaxisIT (US), ExlService Holdings, Inc. (US), Cerner Corporation (US), Cotiviti, Inc. (US), Inovalon (US), CitiusTech Inc (US), Saama Technologies, LLC. (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot Inc. (US), Alteryx, Inc. (US), Sisense Inc. (US), Amazon Web Services, Inc., and Veeva Systems (US).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=174990653
According to the new market research report "Filter
Integrity Test Market by Test Type (Bubble Point, Diffusion, Water
Flow), Mechanism (Manual, Automation), Filter Type (Air, Liquid), End User
(Biopharmaceutical Companies, Contract Manufacturing Organizations, Academics)
- Global Forecast to 2024", published by MarketsandMarkets™, the market
for Filter Integrity Test is projected to reach USD 79 million by 2024 from USD
59 million in 2018, at a CAGR of 5.0% during the forecast period.
Browse in-depth TOC on "Filter Integrity Test
Market"
80 – Tables
27 – Figures
106 – Pages
Request Sample of Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=46873904
The Asia Pacific filter integrity test market, particularly
in China, Japan, India, and South Korea, is expected to witness high growth in
the coming years. Growth in these markets will be fueled by factors such as
significant investments by key market players, increasing government support,
developing R&D infrastructure, increasing outsourcing, and growing
expertise and academic excellence.
The growth of the global filter integrity test market is
mainly driven by the increasing R&D spending across the globe, growth in
the biopharmaceutical industry, and increasing purity requirements.
The major players in the filter integrity test market
are Merck KGaA (Germany), Danaher Corporation/Pall Corporation (US), Sartorius
(Germany), Donaldson Company (US), Parker Hannifin Corporation (US), Meissner
Filtration Product (US), MDI Filtration Technologies (US), Thermo Fisher
Scientific (US), Eaton Corporation (Ireland), and SH-Surway (China).
Sartorius is one of the leading players in the filter
integrity test market. The company has a wide range of product offerings, which
include filter integrity tests, transfer equipment, bottles, and bags. The
company mainly focuses on product innovation and has a strong geographic
presence in Europe, the Americas, and the Asia Pacific. The company is expected
to grow at a positive rate in the market due to its superior product offerings.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46873904
Merck is also a prominent player in the filter
integrity test market. The company has a strong geographic presence across the
Americas, Europe, Asia Pacific, and the Middle East and Africa. Merck focuses
on inorganic strategies to maintain its leading position in this market. For
instance, in 2018, the company signed a MoU with Schneider Electric (France) to
automate biopharmaceutical processes for China’s biopharmaceutical industry.
Recent Developments:
·
Thermo Fisher Scientific opened the new
Bioprocess Design Center in Shanghai, China to connect and collaborate with
biologic developers to design bioprocessing solutions.
·
Merck opened a new manufacturing and
distribution center for its life science business in Mumbai, India to increase
its gross domestic product storage and meet future bioproduction demand.
·
Thermo Fisher Scientific acquired the Advanced
Bioprocessing business from Becton, Dickinson and Company. With this
acquisition, the company expanded its product portfolio of life sciences
solutions.
Request for Custom Research @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=46873904
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies' revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of incremental
revenues for both the company and its competitors. MarketsandMarkets™ now
coming up with 1,500 MicroQuadrants (Positioning top players across leaders,
emerging companies, innovators, strategic players) annually in high growth
emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000
companies this year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets's flagship competitive intelligence and
market research platform, "Knowledge Store" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/filter-integrity-test-market.asp
Visit Our Website: https://www.marketsandmarkets.com
The global cardiovascular information system market is expected to reach USD 917.2 Million by 2020 from USD 621.4 Million in 2015, at a CAGR of 8.1%. On the basis of type, the cardiovascular information systems market is segmented into CVIS and C-PACS. The CVIS segment is projected to grow at the highest CAGR from 2015 to 2020, owing to the increasing incidence and prevalence of cardiovascular diseases.
Cardiology Information System Market is Anticipated to Grow at a CAGR of 8.9% from 2020 to 2024
Growth in this market is driven by the rising incidence of cardiovascular disease in China, government initiatives for HCIT development, and the increasing number of hospitals in China. Moreover, the use of cloud-based solutions is expected to provide growth opportunities for players in the China cardiology information system market during the forecast period. On the other hand, integration and interoperability issues pose major challenges for solution vendors in this market. Key players in the China cardiology information system market include Philips Healthcare (Netherlands), CREALIFE Medical Technology (China), Central Data Network (Australia), Infinitt Healthcare (South Korea), and Esaote (Italy).
Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=264168583
The China cardiology information system market is projected to reach USD 54 million by 2024 from USD 35 million in 2019, at a CAGR of 8.9%.
Integrated systems accounted for the largest share of the China cardiology information system market in 2018
On the basis of system, the China cardiology information system market is segmented into integrated and standalone systems. In 2018, integrated systems accounted for the largest share of the China cardiology market. The large share of this segment can be attributed to the increasing adoption of these systems by healthcare providers and the increasing incidence prevalence of cardiovascular diseases.
By component, the software segment accounted for the largest market share in 2018
On the basis of component, the China cardiology information system market is segmented into software, hardware, and service. The software segment accounted for the largest market share in 2018. This is attributed to the rising number of hospitals and the consequent increase in the demand for CVIS and CPACS, among other technologies.
L3A Hospitals are the largest end users in the China cardiology information system market
Based on end user, the China cardiology information system market is segmented into L3A, L3B, and L2 hospitals. The L3A hospitals segment accounted for the largest market share in 2018. The increasing number of L3A hospitals and the rising incidence of cardiovascular diseases in China are the major market drivers for this segment.
The key players in the China cardiology information system market are Philips Healthcare (Netherlands), CREALIFE Medical Technology (China), Central Data Network (Australia), Infinitt Healthcare (South Korea), and Esaote (Italy).
CREALIFE Medical Technology (China) dominated the China cardiology information technology market. The company is engaged in the RD and supply of medical image process technology and Internet solutions. It provides high-grade analysis of medical images and advanced international specialized solutions.
Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=264168583
Don’t miss out on business opportunities in Cardiology Information System Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
Global solvent evaporation market size is projected to reach USD 694 million by 2024 from USD 487 million in 2019, at a CAGR of 7.3%. The North American market is estimated to account for the largest share. The large share of this segment can be attributed to the increase in life sciences R&D, rising focus on improving the safety and quality of healthcare, growing efforts to increase the output of the healthcare industry, growth in the biosimilars and generics market, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics.
Request Sample of Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=68290365
Growth in this market is driven majorly by the growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large molecule biopharmaceuticals.
Key Market Players
The prominent players in the global solvent evaporation market include Yamato Scientific Co., Ltd. (Japan), BÜCHI Labortechnik AG (Switzerland), Biotage AB (Sweden), Heidolph Instruments GmbH & CO. KG (Germany), Labconco Corporation (US), Porvair plc (UK), IKA Works GmbH & Co. KG (Germany), Steroglass Srl (Italy), Organomation Associates, Inc. (US), KNF Neuberger, Inc. (US), BioChromato, Inc. (Japan), Radleys (UK), LabTech S.r.l. (Italy), Abel Industries Canada Ltd. (Canada), DOÐA Limited (Turkey), ANPEL Laboratory Technologies Inc. (China), Asahi Glassplant Inc. (Japan), EYELA (Japan), Pope Scientific, Inc. (US), and SP Industries, Inc. (UK).
BÜCHI Labortechnik AG (Switzerland) is a prominent player in the global solvent evaporators market. The company has a strong geographic footprint, serving over 40,000 customers operating in the pharmaceutical and biopharmaceutical space. BÜCHI also has an extensive distribution channel across the globe. The company offers a variety of reliable solutions during the production of a new drug, from lead generation to final registration.
Heidolph Instruments GmbH & CO. KG (Germany) is a leading provider of advanced rotary evaporators for drug manufacturing, biologics research and production, and laboratory testing. Heidolph’s key advantage over its competitors is that it leverages its industry scale in high-growth and emerging markets such as China and India.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68290365
Biotage AB (Sweden) offers a wide range of nitrogen blowdown evaporators like TurboVap Evaporators and 96 Well Plate Evaporators. As a solvent evaporator manufacturer, the company provides integrated products with various technologies that span the whole pharmaceutical value chain. The major end-users of the company’s products include pharmaceutical and biotechnology companies, government research institutes, consumer and healthcare product manufacturers, formulators, and diagnostic laboratories.
Recent Developments
Request for Custom Research @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=68290365
The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period. The North American nuclear medicine market is segmented into the US and Canada, based on country. The US is expected to account for the largest share and also register the highest CAGR during the forecast period.
According to the new market research report "North American Nuclear Medicine Market by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) - Forecasts to 2024", published by MarketsandMarkets™, the North American Radiopharmaceuticals Market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, at a CAGR of 4.1%.
Request Sample of Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1108
The key factors driving the growth of this market are increasing incidence and prevalence of cancer & cardiac ailments and the initiatives to lessen the demand-supply gap of Mo-99.
Key Market Players
Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).
Cardinal Health (US) is one of the major players in the North American nuclear medicine market. Cardinal Health is a healthcare services company providing pharmaceutical and medical products & services to healthcare providers. Cardinal Health operates in the US, Canada, the British Virgin Islands, Malaysia, Singapore, the UK, Luxembourg, Thailand, Switzerland, Ireland, and Belgium through its 150 subsidiaries.
Curium (France) is another major player in the North American nuclear medicine market. Curium started its operations in 2017 through the union of two major players—IBA Molecular (France) and Mallinckrodt Pharmaceuticals (Ireland)—in the nuclear medicine market. Curium focuses on innovation, and it invested ~USD 3 million to build a new R&D laboratory
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1108
GE Healthcare (US) has a huge network of radiopharmacies and a robust customer base in approximately 175 countries, primarily operating in North America, Europe, the Pacific Basin, the Americas, and the Middle East & Africa.
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the North American nuclear medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Request for Custom Research @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1108
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/north-american-nuclear-medicine-radiopharmaceuticals-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/north-american-nuclear-medicine-radiopharmaceuticals.asp
Global Pedicle Screw System Market guarantees you will remain better informed than your competition. This study provides the broader perspective of the market place with its comprehensive market insights and analysis which eases surviving and succeeding in the market. Global Pedicle Screw System market report through its market research helps improve and modify products so that the necessary changes to the future products can be made and more satisfaction is presented to the valuable customers.
Request for Free Sample Report @
https://www.marketsandmarkets.com/requestsample.asp?id=98811670
The Pedicle Screw Systems Market is expected to reach USD 724.23 million by 2023 from USD 538.64 million in 2018, at a CAGR of 6.1%.
The report analyzes and studies the major drivers, restraints, opportunities, and challenges of the Pedicle Screw System Market in North America, Europe, Asia Pacific, and the Rest of the World (RoW). The high incidence of sports injuries, growing geriatric population, rising inclination of patients and hospitals towards minimally invasive surgeries, technological advancements in arthroscopy products, and an efficient reimbursement system in developed countries are some of the factors driving the growth of the market.
The increasing incidence of spinal cord injuries, increasing aging population, and technological advancements are major factors driving the growth of the Pedicle Screw Systems Market.
Polyaxial pedicle screw systems are expected to account for the largest market share
On the basis of product type, the Pedicle Screw Systems Market is segmented into monoaxial, polyaxial, and other pedicle screw systems. the polyaxial pedicle screw systems segment is expected to account for the largest share of the global Pedicle Screw Systems Market. The large share of this market segment can be attributed to the increasing prevalence of spinal cord disorders and product launches.
Browse in-depth TOC on "Pedicle Screw Systems Market"
66 - Tables
36 - Figures
110 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/pedicle-screw-system-market-98811670.html
Open surgery is estimated to account for the largest share of the Pedicle Screw Systems Market
By surgery type, the Pedicle Screw Systems Market has been segmented into open surgery and minimally invasive surgery. the open surgery segment is expected to account for the largest share of the Pedicle Screw Systems Market due to the rising geriatric population, increasing incidence of spinal deformities, and technological advancements in spinal fusion surgeries.
The spinal degeneration segment is estimated to grow at the highest CAGR during the forecast period
By indication, the market includes spinal degeneration, spinal trauma, spinal deformities, and other indications. The spinal degeneration segment is estimated to register the highest CAGR during the forecast period. The high prevalence of degenerative spine disorders is expected to result in a growing volume of surgical procedures performed.
North America is estimated to command the largest share of the market
Based on region, the Pedicle Screw Systems Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global Pedicle Screw Systems Market.
Key Market Players
Key players in the Pedicle Screw Systems Market include DePuy Synthesis (US), Globus Medical (US), Zimmer Biomet (US), B. Braun (US), Medtronic (Ireland), and Stryker (US).
Speak to Our Analyst and gain crucial industry insights that will help your business grow:
https://www.marketsandmarkets.com/speaktoanalyst.asp?id=98811670
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]